The program aims to provide an overview of genomic medicine and pharmacogenetics, review specialties where advancements in pharmacogenetics can improve the quality of care, and offer perspective from leading experts in how pharmacogenetics can transform clinical practice. Despite patient and clinician interest in genomic medicine, education is often the limiting factor to clinical application. The program will include general concepts necessary for foundational knowledge in genomic medicine. Attendees will be exposed to a variety of use cases for pharmacogenetics (e.g., pain management, psychiatry, cardiology) and molecular tumor profiling in oncology. Case-based discussions will allow practitioners and healthcare professionals to hear and discuss real-world experiences in using pharmacogenetics in the daily practice of medicine.

Activity Director’s Name:

Sandra Swain, MD; Max Smith, PhD

The following planning committee members and faculty members have reported no relevant financial relationships:

Sandra Swain, MD; Max Smith, PhD; James Welsh, MD, PhD, MPH; Elizabeth Hwang, MHA

No commercial support has been provided for this activity.

Target Audience:

This conference is intended for primary care providers, family practitioners, oncologists, psychiatrists, cardiologists, physician assistants, nurse practitioners, pharmacists and all other members of the healthcare team interested in pharmacogenomics.

To Earn Credit:

1. View all 8 videos
2. Complete the test following the last video of this activity
3. Complete the activity evaluation

Failure to complete any of these steps will result in a failure to be awarded CE by the system. 

Evaluation:

Please note, the evaluation must be completed to receive credit for viewing this activity. 

1. Summarize foundational concepts related to genomic medicine and pharmacogenetics
2. Identify key resources for the clinical application of pharmacogenetics
3. Recognize that evidence levels vary between different drug-gene pairs
4. Identify clinical scenarios where a genetic result can guide therapy
5. Explain how pharmacogenetic results can be used in prescribing decisions
6. Explain how pharmacogenetic results can be integrated into pharmacy practice

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC)  to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 4.5 Interprofessional Continuing Education (IPCE) credits for learning and change.